1-5 of 5
Takahiro Nagashima, MD
Close
Sort by
Journal Articles

First-Line Dasatinib Treatment of CML-CP Leads to Earlier Achievement of MMR and MR4.5 with High Safety

Kazunori Murai, MD, PhD, Kohei Yamaguchi, MD, Shigeki Ito, MD, PhD, Takuto Miyagishima, MD, PhD, Motohiro Shindo, MD PhD, Kentaro Wakasa, MD, PhD, Mitsue Inomata, MD, PhD, Takahiro Nagashima, MD, PhD, Takeshi Kondo, MD PhD, Nozomu Fujimoto, MD, PhD, Satoshi Yamamoto, PhD MD, Masakatsu Yonezumi, MD, PhD, Tatsuo Oyake, MD, PhD, Shugo Kowata, MD PhD, Yasuhiko Tsukushi, MD PhD, Takahiro Mine, MD, Kuniaki Meguro, MD PhD, Kazuhiko Ikeda, MD PhD, Reiko Watanabe, MD PhD, Souichi Saito, MD, PhD, Shinji Sato, MD, PhD, Takaaki Chou, MD, PhD, Kohmei Kubo, MD, PhD, Koji Oba, PhD, Junichi Sakamoto, MDPhD, Yoji Ishida, MD, PhD
Journal: Blood
Blood (2016) 128 (22): 3102.
https://doi.org/10.1182/blood.V128.22.3102.3102
Published: 2016
Journal Articles

Pharmacokinetic (PK) and Pharmacodynamic (PD) Study Of Dasatinib In Chronic Phase Of Newly Diagnosed Chronic Myeloid Leukemia (CML-CP)

Yoji Ishida, M.D., Ph.D., Kazunori Murai, MD, PhD, Kohei Yamaguchi, M.D., Takuo Miyagishima, MD, PhD, Motohiro Shindo, M.D., Ph.D., Kazuei Ogawa, M.D., Ph.D., Takahiro Nagashima, MD, PhD, Shinji Sato, MD, PhD, Reiko Watanabe, M.D., Ph.D., Satoshi Yamamoto, MD, PhD, Takaaki Hirose, MD, PhD, Yuichi Kato, MD, PhD, Masakatsu Yonezumi, M.D. PhD, Takeshi Kondo, MD., PhD, Nobuo Mochizuki, PhD, Keiko Ohno, PhD, Satoshi Kishino, PhD, Shigeki Ito, M.D., Ph.D., Komei Kubo, MD, PhD, Sohichi Saito, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 4031.
https://doi.org/10.1182/blood.V122.21.4031.4031
Published: 2013
Journal Articles

HIF-1 Supports the Survival of Multiple Myeloma Cells through the Induction of Survivin Gene.

Keita Kirito, MD, PhD, Hu Yongzhen, MD, Kozue Yoshida, MD, Toru Mitsumori, MD, Kei Nakajima, MD, Yumi Nozaki, MD, Takahiro Nagashima, MD, Masae Kunitama, MD, Kumi Sakoe, PhD, Norio Komatsu, MD, PhD
Journal: Blood
Blood (2007) 110 (11): 110.
https://doi.org/10.1182/blood.V110.11.110.110
Published: 2007
Journal Articles

A Novel Inherited Single-Nucleotide Mutation in 5′-UTR in the Transcription Factor RUNX1 in Familial Platelet Disorder with Propensity To Develop Myeloid Malignancies.

Keita Kirito, MD, PhD, Toru Mitsumori, MD, Takahiro Nagashima, MD, Masae Kunitama, MD, Kei Nakajima, MD, Kozue Yoshida, MD, Yongzhen Hu, MD, Mitsuhiro Yanagai, MD, Norio Komatsu, MD,PhD
Journal: Blood
Blood (2006) 108 (11): 1917.
https://doi.org/10.1182/blood.V108.11.1917.1917
Published: 2006
Journal Articles

Usefulness of FDG-PET (Positron Emission Tomography) in the Discrimination between Hypoplastic Myelodysplastic Syndromes and Aplastic Anemia.

Masaaki Takatoku, MD, PhD, Takahiro Nagashima, MD, Toshihiko Sato, MD, Tadashi Nagai, MD, PhD, Norio Komatsu, MD, PhD, Keiya Ozawa, MD, PhD
Journal: Blood
Blood (2004) 104 (11): 4738.
https://doi.org/10.1182/blood.V104.11.4738.4738
Published: 2004